bioAffinity Technologies, Inc. (BIAF)
NASDAQ:BIAF
US Market
Holding BIAF?
Track your performance easily

bioAffinity Technologies, Inc. (BIAF) Financial Statements

38 Followers

bioAffinity Technologies, Inc. Financial Overview

bioAffinity Technologies, Inc.'s market cap is currently ―. The company's EPS TTM is $-0.903; its P/E ratio is -2.23; bioAffinity Technologies, Inc. is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $-0.15. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 2.40M$ 2.41M$ 2.21M$ 298.48K$ 19.74K
Gross Profit$ 2.40M$ 2.41M$ 2.29M$ 223.78K$ 18.50K
EBIT$ -2.08M$ -1.93M-$ -2.28M$ -1.73M
EBITDA$ -1.93M$ -1.78M-$ -2.22M$ -1.71M
Net Income Common Stockholders$ -2.11M$ -339.41K$ -2.37M$ -2.08M$ -1.74M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 800.00K$ 2.50M$ 2.80M$ 4.50M$ 8.30M
Total Assets$ 6.66M$ 8.10M$ 8.22M$ 10.19M$ 8.89M
Total Debt$ 1.38M$ 1.49M$ 1.58M$ 1.69M$ 42.33K
Net Debt$ 580.00K$ -1.01M$ -1.22M$ -2.81M$ -8.26M
Total Liabilities$ 3.22M$ 2.79M$ 3.37M$ 3.20M$ 775.15K
Stockholders Equity$ 3.43M$ 5.22M$ 4.86M$ 6.99M$ 8.14M
Cash Flow-
Free Cash Flow$ -1.56M$ -2.39M-$ -1.53M$ -1.36M
Operating Cash Flow$ -1.53M$ -2.35M$ -1.62M$ -1.53M$ -1.36M
Investing Cash Flow$ -28.29K$ -41.39K$ 13.44K$ -2.19M$ -3.86K
Financing Cash Flow$ -91.14K$ 2.02M$ -84.81K$ -50.77K$ -126.10K
Currency in USD

bioAffinity Technologies, Inc. Earnings and Revenue History

bioAffinity Technologies, Inc. Debt to Assets

bioAffinity Technologies, Inc. Cash Flow

bioAffinity Technologies, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis